Non-fatal overdose in the 12 months following treatment for substance use disorders

被引:48
作者
Britton, Peter C. [1 ,2 ]
Wines, James D., Jr. [3 ,4 ]
Conner, Kenneth R. [1 ,2 ]
机构
[1] Dept Vet Affairs Med Ctr, Ctr Excellence, Canandaigua, NY 14424 USA
[2] Univ Rochester, Sch Med & Dent, Dept Psychiat, Ctr Study & Prevent Suicide, Rochester, NY 14642 USA
[3] McLean Hosp, Alcohol & Drug Abuse Res Ctr, Belmont, MA 02478 USA
[4] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA
关键词
Epidemiology; Overdose; Treatment; Risk factors; Sexual abuse; Intravenous drug abuse; DRUG-ABUSE TREATMENT; HEROIN-RELATED DEATHS; TAKE-HOME NALOXONE; SUICIDE ATTEMPTS; SEXUAL-ABUSE; CHRONIC PAIN; AUSTRALIA; METHADONE; PREVALENCE; SYDNEY;
D O I
10.1016/j.drugalcdep.2009.09.005
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
100404 [儿少卫生与妇幼保健学];
摘要
Background: Overdose (OD) is a leading Cause of mortality and morbidity for individuals with substance use disorders (SUDS), and there are limited prospective data on OD during the months following treatment for SUDS. Methods: Variables associated with an OD in the 12 months after leaving an initial treatment episode were examined in an analysis of the Drug Abuse Treatment Outcomes Study (DATOS), a longitudinal naturalistic multisite study. Participants included 2966 patients with one or more SUDS. Non-fatal OD was ascertained by a positive response to "In the past 12 months, have you overdosed on drugs?" Multivariate logistic regression analyses were used to identify variables associated with OD. Results: By 12 months, 93 (3.1%) participants reported one or more ODs. Variables associated with OD were lifetime history of OD, injection drug use (IDU), male sex, greater pain, and history of sexual abuse. Conclusions: OD-risk appears to be increased by IDU, lifetime OD, sexual abuse history, and pain. The latter finding is novel for a prospective report and requires further study. Published by Elsevier Ireland Ltd.
引用
收藏
页码:51 / 55
页数:5
相关论文
共 47 条
[1]
American Psychiatric Association, 2013, Diagnostic and statistical manual of mental disorders, DOI 10.1176/appi.books.9780890425596
[2]
Take-home naloxone to reduce heroin death [J].
Baca, CT ;
Grant, KJ .
ADDICTION, 2005, 100 (12) :1823-1831
[3]
Increase in deaths due to methadone in North Carolina [J].
Ballesteros, MF ;
Budnitz, DS ;
Sanford, CP ;
Gilchrist, J ;
Agyekum, GA ;
Butts, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01) :40-40
[4]
Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration [J].
Brugal, MT ;
Barrio, G ;
De La Fuente, L ;
Regidor, E ;
Royuela, L ;
Suelves, JM .
ADDICTION, 2002, 97 (03) :319-327
[5]
*CDCP, 2008, WISQ INJ MORT REP 19
[6]
Coll X, 1998, ARCH SUICIDE RES, V4, P291, DOI 10.1080/13811119808258305
[7]
Abuse and deliberate self-poisoning in women:: a matched case-control study [J].
Coll, X ;
Law, F ;
Tobías, A ;
Hawton, K ;
Tomàs, J .
CHILD ABUSE & NEGLECT, 2001, 25 (10) :1291-1302
[8]
Major increases in opioid analgesic abuse in the United States: Concerns and strategies [J].
Compton, WM ;
Volkow, ND .
DRUG AND ALCOHOL DEPENDENCE, 2006, 81 (02) :103-107
[9]
Suicide attempts among individuals with opiate dependence: The critical role of belonging [J].
Conner, Kenneth R. ;
Britton, Peter C. ;
Sworts, Luke M. ;
Joiner, Thomas E., Jr. .
ADDICTIVE BEHAVIORS, 2007, 32 (07) :1395-1404
[10]
Heroin-related deaths in New South Wales, Australia, 1992-1996 [J].
Darke, S ;
Ross, J ;
Zador, D ;
Sunjic, S .
DRUG AND ALCOHOL DEPENDENCE, 2000, 60 (02) :141-150